COSTAMARE INC. financials

SEC pipeline catching up: most recent reported quarter (2026-03-31) isn't incorporated yet — this page is anchored to 2025-12-31 (FY 2025 · 20-F). New filings land within a few weekday pipeline runs.
CMRE CIK 0001503584

Source: EDGAR filings · Built 2026-06-02T02:40:46Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
EBITDA 585.73M 616.52M 721.69M 828.24M 578.31M 169.03M
Working Capital 292.10M 294.66M 454.89M 591.53M 56.10M -14.92M
Net Debt 994.99M 1.36B 1.94B 1.87B 2.28B 1.44B
Operating Margin 51.96% 55.12% 70.14% 59.46% 55.61% 13.11%
Net Margin 41.53% 36.01% 45.47% 49.82% 54.83% 1.93%
Return on Equity (ROE) 17.48% 12.73% 16.19% 25.73% 25.21% 0.66%
Return on Assets (ROA) 9.44% 6.21% 7.30% 11.33% 9.87% 0.29%
Current Ratio 1.73× 1.40× 1.69× 2.40× 1.15× 0.93×
Debt-to-Equity 0.73× 0.80× 1.11× 1.20× 1.48× 1.18×
Cash Conversion Ratio 1.47× 1.68× 0.86× 1.05× 1.07× 30.90×
Accruals Ratio -0.04× -0.04× 0.01× -0.01× -0.01× -0.09×
SBC % of Revenue 0.80% 0.95% 0.69% 0.64% 0.93% 0.79%

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 5.52× 5.27× 3.53× 2.18× 3.86×
EV / EBITDA 4.95× 4.70× 4.39× 3.62× 6.66× 14.51×
P/S 2.17× 1.73× 1.45× 1.02× 1.98× 2.20×
P/B 0.91× 0.61× 0.52× 0.53× 0.91× 0.75×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 877.90M 888.49M 848.29M 1.11B 793.64M 460.32M
Operating Income (Loss) 456.19M 489.70M 594.97M 662.25M 441.35M 60.33M
Net Income (Loss) Attributable to Parent 364.57M 319.92M 385.75M 554.96M 435.12M 8.88M
Earnings Per Share, Basic $2.86 $2.44 $2.95 $4.26 $3.28 $-0.18
Weighted Average Number of Shares Outstanding, Basic 120.20M 119.30M 120.30M 122.96M 123.07M 120.70M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 519.85M 656.88M 710.61M 718.05M 276.00M 143.92M
Assets, Current 690.67M 1.04B 1.12B 1.01B 426.12M 192.05M
Assets 3.86B 5.15B 5.29B 4.90B 4.41B 3.01B
Long-term Debt 1.51B 1.70B 2.35B 2.58B 2.44B 1.45B
Liabilities, Current 398.57M 745.56M 662.77M 423.09M 370.03M 206.97M
Long-term Debt, Excluding Current Maturities 1.25B 1.41B 2.00B 2.26B 2.17B 1.31B
Stockholders' Equity Attributable to Parent 2.09B 2.51B 2.38B 2.16B 1.73B 1.35B
Common Stock, Shares, Outstanding 120.58M 119.95M 118.37M 122.30M 123.99M 122.16M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 537.72M 331.37M 581.59M 466.49M 274.28M
Net Cash Provided by (Used in) Investing Activities -79.51M 79.09M 42.49M -787.46M -36.40M
Payments for Repurchase of Common Stock 0 0 60.00M 60.09M 0 0
Payments of Dividends 79.29M 74.15M 71.87M 119.55M 71.26M 65.47M
Net Cash Provided by (Used in) Financing Activities -505.48M -396.81M -166.05M 482.59M -241.86M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CMRE CIK 0001503584), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

RPRX

Royalty Pharma plc

BBNX

BETA BIONICS, INC.